• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

关附甲素抗氧化和抗房颤作用

郭巧, 孙建国, 黄潞, 张丽, 于雪莉, 刘静涵, 汤依群

郭巧, 孙建国, 黄潞, 张丽, 于雪莉, 刘静涵, 汤依群. 关附甲素抗氧化和抗房颤作用[J]. 中国药科大学学报, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217
引用本文: 郭巧, 孙建国, 黄潞, 张丽, 于雪莉, 刘静涵, 汤依群. 关附甲素抗氧化和抗房颤作用[J]. 中国药科大学学报, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217
shu
GUO Qiao, SUN Jianguo, HUANG Lu, ZHANG Li, YU Xueli, LIU Jinghan, TANG Yiqun. Antioxidant and anti-atrial fibrillation effects of Guanfu base A[J]. Journal of China Pharmaceutical University, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217
Citation: GUO Qiao, SUN Jianguo, HUANG Lu, ZHANG Li, YU Xueli, LIU Jinghan, TANG Yiqun. Antioxidant and anti-atrial fibrillation effects of Guanfu base A[J]. Journal of China Pharmaceutical University, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217
shu

关附甲素抗氧化和抗房颤作用

  • 中国药科大学临床药学教研室

基金项目: 国家“重大新药创制”科技重大专项课题资助项目(No.2009ZX09103-345)

Antioxidant and anti-atrial fibrillation effects of Guanfu base A

摘要

    摘要
  • 摘要: 研究关附甲素(Guanfu base A，GFA)的抗房颤和抗氧化作用。大鼠尾静脉注射乙酰胆碱-氯化钙混合液(CaCl2 10 mg/mL，Ach 66 μg/mL)，连续7 d建立房颤模型。SD大鼠分为正常组、模型组、GFA治疗组(6 mg/kg，12 mg/kg)、胺碘酮(Amiodarone，Ami)治疗组(50 mg/kg)以及洛伐他汀(Lovastatin，Lov)治疗组(10 mg/kg)。测定大鼠房颤持续时间和有效不应期(AERP)，用实时荧光定量PCR方法和Western blot方法测定氧化应激相关基因表达，试剂盒测定抗氧化酶的活性。结果显示:与模型组相比，GFA(6 mg/kg，12 mg/kg，po)治疗4 d后能缩短房颤持续时间，延长AERP，超氧化物歧化酶的活力提高，丙二醛含量明显下降。心房肌p22phox、p47phox、p67phox、gp91phox表达下调，膜Rac-1与胞浆Rac-1比值显著下降，缝隙连接蛋白(connexin40)表达升高。提示GFA(6 mg/kg，12 mg/kg)能有效抑制房颤引起的大鼠心房氧化应激损害，抑制房颤发生。
    Abstract: This study aimed at evaluating the antioxidant effects of Guanfu base A(GFA)on acetylcholine(Ach)/CaCl2(CaCl2 10 mg/mL, Ach 66 μg/mL)-induced atrial fibrillation(AF)in rats. SD rats were rando-mized into normal group, model group, GFA treatment groups(6 mg/kg, 12 mg/kg), Amiodarone(Ami)treatment group(50 mg/kg)and Lovastatin(Lov)treatment group(10 mg/kg). The AF durations were measured by electrocardiogram(ECG). The effective refractory periods(AERP)were measured in the left atrial appendage. Oxidative stress-related gene and protein expression was evaluated by RT-PCR and Western blot. The activity of antioxidant enzymes was measured by enzymatic assay. Results indicated that, in comparison with that in the vehicle-treated AF rats, treatment with GFA(6 mg/kg, 12 mg/kg, po), significantly shortened the AF duration and prolonged the AERP in rats. In addition, treatment with GFA reduced the levels of plasma and myocardium malondialdehyde, increased the activity of plasma superoxide dismutase in a dose-dependent manner. Moreover, treatment with GFA mitigated AF-up-regulated p22phox, p47phox, gp91phox, and p67phox NADPH oxidase expression, and AF-increased ratios of membrane to cytosolic Rac-1 in the atrium. It also significantly prevented AF-down-regulated atrial connexin40 expression in rats. Data suggested that GFA(6 mg/kg, 12 mg/kg)has potent anti-oxidant activity and inhibits oxidative-stress-related AF in rats.
    • HTML全文
    • 参考文献(20)
  • [1] Schneider MP, Hua TA,Böhm M,et al.Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis[J].J Am Coll Cardiol,2010,55(21):2299-2307.
    [2] Korantzopoulos P,Kolettis T,Siogas K,et al.Atrial fibrillation and electrical remodeling:the potential role of inflammation and oxidative stress[J].Med Sci Monitor,2003,9(9):RA225-RA229.
    [3] Mccarty MF.Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies[J].Med Hypotheses,2010,75(2):141-147.
    [4] Arora S,Vaishya R,Dabla PK,et al.NAD(P)H oxidases in coronary artery disease[J].Adv Clin Chem,2010,50:65-86.
    [5] Bedard K,Krause KH.The NOX family of ROS-generating NADPH oxidases:physiology and pathophysiology[J].Physiol Rev,2007,87(1):245-313.
    [6] Reilly SN,Jayaram R,Nahar K,et al.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation implications for the antiarrhythmic effect of statins[J].Circulation,2011,124(10):1107-1117.
    [7] Wang MW,Hao X,Chen K.Biological screening of natural products and drug innovation in China[J].Philos T R Soc B,2007,362(1482):1093-1105.
    [8] Zhang LY,Ji HF,Wang Q,et al.Effects of Guanfu base A on the electrical characterization of cardiac myocyted[J].J China Pharm Univ(中国药科大学学报),1991,22(6):354-358.
    [9] Huang X, Yang Y, Zhu J, et al. Comparative effects of guanfu base A and guanfu base G on HERG K+ channel[J].J Cardiovascr Pharm,2012,59(1):77-83.
    [10] Fan X,Chen Y,Xing J,et al.Blocking effects of acehytisine on pacemaker currents(If)in sinoatrial node cells and human HCN4 channels expressed in xenopus laevis oocytes[J].J Ethnopharmacol,2012,139(1):42-51.
    [11] Chen CL,Gong TT,Tang TQ,et al.Sprague Dawley rat model of atrial fibrillationthe[J].Lab Anim Sci Administ(实验动物科学与管理),2009,26(3):1-4.
    [12] Savelieva I,Camm J.Anti-arrhythmic drug therapy for atrial fibrillation:current anti-arrhythmic drugs,investigational agents,and innovative approaches[J].Europace,2008,10(6):647-665.
    [13] Tang YQ,Sun SJ,Yin YM,et al.Electrical remodeling of rat atrium induced by paroxysmal atrial fibrillation[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2011,16(11):1205-1209.
    [14] Beckerman Z,Azran A,Cohen O,et al.A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation first animal trial[J].J Cardiovasc Pharm T,2014,19(3):481-491.
    [15] Carnes CA,Chung MK,Nakayama T,et al.Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation[J].Circ Res,2001,89(6):e32-e38.
    [16] Kim YM,Guzik TJ,Zhang YH,et al.A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation[J].Circ Res,2005,97(7):629-636.
    [17] Ehrlich JR, Biliczki P, Hohnloser SH, et al. Atrial-selective approaches for the treatment of atrial fibrillation[J].J Am Coll Cardiol,2008,51(8):787-792.
    [18] Sanchez-Quinones J,Marin F,Roldan V,et al.The impact of statin use on atrial fibrillation[J].Qjm-Int J Med,2008,101(11):845-861.
    [19] Reilly SN,Jayaram R,Nahar K,et al.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation implications for the antiarrhythmic effect of statins[J].Circulation,2011,124(10):1107-1117.
    [20] Umeji K,Umemoto S,Itoh S,et al.Comparative effects of pitavastatin and probucol on oxidative stress,Cu/Zn superoxide dismutase,PPAR-γ,and aortic stiffness in hypercholesterolemia[J].Am J Physiol-Heart C,2006,291(5):H2522-H2532.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  1060
  • HTML全文浏览量:  0
  • PDF下载量:  1506
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-04-24

目录

摘要
HTML全文
    参考文献(20)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    版权所有：《中国药科大学学报》编辑部苏ICP备05007142号

    地址：江苏省南京市鼓楼区童家巷24号（210009）电话: 025-83271566E-mail: xuebao@cpu.edu.cn

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    访问量：459371

    x 关闭 永久关闭